Kubota Pharmaceutical Holdings Co's quarterly market cap
increased
from Jun. 2025 (円2,938.33 Mil) to Dec. 2025 (円4,846.97 Mil) and
increased
from Dec. 2025 (円4,846.97 Mil) to Mar. 2026 (円13,711.90 Mil).
Kubota Pharmaceutical Holdings Co's annual market cap
declined
from Dec. 2023 (円4,485.04 Mil) to Dec. 2024 (円3,008.55 Mil) but then
increased
from Dec. 2024 (円3,008.55 Mil) to Dec. 2025 (円4,846.97 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Kubota Pharmaceutical Holdings Co's Enterprise Value for Today is 円6,064.90 Mil.
Kubota Pharmaceutical Holdings Co (TSE:4596) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Kubota Pharmaceutical Holdings Co Market Cap Related Terms
Kubota Pharmaceutical Holdings Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kubota Pharmaceutical Holdings Co Market Cap Chart
TSE:4596 vs VRTX, REGN, ALNY: Market Cap Comparison
For the Biotechnology subindustry, Kubota Pharmaceutical Holdings Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kubota Pharmaceutical Holdings Co Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Kubota Pharmaceutical Holdings Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Kubota Pharmaceutical Holdings Co's Market Cap falls into.
Kubota Pharmaceutical Holdings Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kubota Pharmaceutical Holdings Co (TSE:4596) has a Market Cap of 円7,713.43 Mil as of Jul. 02, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Kubota Pharmaceutical Holdings Co and its competitors. According to the industry distribution chart, Kubota Pharmaceutical Holdings Co ranks #910 out of 1427 companies in the Biotechnology industry, placing it in the top 63.8%.
Is Kubota Pharmaceutical Holdings Co's Market Cap too high?
Kubota Pharmaceutical Holdings Co's current Market Cap is 円7,713.43 Mil. Based on the distribution chart, Kubota Pharmaceutical Holdings Co ranks #910 out of 1427 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Kubota Pharmaceutical Holdings Co has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Kubota Pharmaceutical Holdings Co's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Kubota Pharmaceutical Holdings Co ranks #910 out of 1427 companies for Market Cap. This places Kubota Pharmaceutical Holdings Co in the lower half of its industry. The industry median Market Cap is 119.04. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 119.04, based on 1,427 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Kubota Pharmaceutical Holdings Co and its competitors. For the Biotechnology industry, the median Market Cap is 119.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kubota Pharmaceutical Holdings Co's current Market Cap is 円7,713.43 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kubota Pharmaceutical Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Kubota Pharmaceutical Holdings Co (TSE:4596) is currently considered Significantly Overvalued. The stock's GF Value™ is 円39.99, compared to a current price of 円55.00 — trading 37.5% above its estimated fair value. The current Market Cap is 円7,713.43 Mil. Kubota Pharmaceutical Holdings Co's overall GF Score™ is 49/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Kubota Pharmaceutical Holdings Co (TSE:4596), the current Market Cap is 円7,713.43 Mil as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kubota Pharmaceutical Holdings Co (TSE:4596) Overvalued in 2026?
Based on GuruFocus' analysis, Kubota Pharmaceutical Holdings Co stock appears to be overvalued.
The current stock price of 円55.00 is trading 37.5% above its estimated GF Value™ of 円39.99.
GuruFocus considers Kubota Pharmaceutical Holdings Co to be Significantly Overvalued.
Key valuation signals for TSE:4596:
Market Cap: 円7,713.43 Mil
GF Value™: 円39.99 vs. price of 円55.00 (37.5% above fair value)
No single metric tells the full story. See the TSE:4596 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kubota Pharmaceutical Holdings Co Business Description
Kubota Pharmaceutical Holdings Co Ltd is a Japanese company providing portfolio of drugs and devices to preserve and restore millions of people. It identifies and develops therapeutics to treat the opthalmic disorder and operations incidental or related thereto. Its pipeline products include VCM-Emixustat HCI, Lanosterol and Optogenetics.
49GF Score
Get the complete analysis for TSE:4596
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4596 has been successfully added to your 
